These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours. Pipinikas CP; Berner AM; Sposito T; Thirlwell C Endocr Relat Cancer; 2019 Aug; 26(9):R519-R544. PubMed ID: 31252410 [TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis. Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289 [TBL] [Abstract][Full Text] [Related]
8. Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids. Dreijerink KM; Derks JL; Cataldo I; Scarpa A; Valk GD; Speel EJ Front Horm Res; 2015; 44():115-38. PubMed ID: 26303708 [TBL] [Abstract][Full Text] [Related]
9. Genetics and epigenetics in small intestinal neuroendocrine tumours. Stålberg P; Westin G; Thirlwell C J Intern Med; 2016 Dec; 280(6):584-594. PubMed ID: 27306880 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of SST Klomp MJ; Refardt J; van Koetsveld PM; Campana C; Dalm SU; Dogan F; van Velthuysen MF; Feelders RA; de Herder WW; Hofland J; Hofland LJ Front Endocrinol (Lausanne); 2023; 14():1184436. PubMed ID: 37223009 [TBL] [Abstract][Full Text] [Related]
11. Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines. Boora GK; Kanwar R; Kulkarni AA; Pleticha J; Ames M; Schroth G; Beutler AS; Banck MS Cancer Genet; 2015; 208(7-8):374-81. PubMed ID: 26087898 [TBL] [Abstract][Full Text] [Related]
12. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours. Scarpa A Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors. Larsson C Neuroendocrinology; 2013; 97(1):19-25. PubMed ID: 22456267 [TBL] [Abstract][Full Text] [Related]
15. Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours. Kajiura K; Takizawa H; Morimoto Y; Masuda K; Tsuboi M; Kishibuchi R; Wusiman N; Sawada T; Kawakita N; Toba H; Yoshida M; Kawakami Y; Naruto T; Imoto I; Tangoku A; Kondo K Lung Cancer; 2017 Sep; 111():116-123. PubMed ID: 28838380 [TBL] [Abstract][Full Text] [Related]
16. Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective. Finnerty BM; Gray KD; Moore MD; Zarnegar R; Fahey Iii TJ World J Gastrointest Oncol; 2017 Sep; 9(9):341-353. PubMed ID: 28979716 [TBL] [Abstract][Full Text] [Related]
17. Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead. Colao A; de Nigris F; Modica R; Napoli C Front Endocrinol (Lausanne); 2020; 11():604341. PubMed ID: 33384663 [TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites. Pareja F; Vahdatinia M; Marchio C; Lee SSK; Da Cruz Paula A; Derakhshan F; da Silva EM; Selenica P; Dopeso H; Chandarlapaty S; Wen HY; Vincent-Salomon A; Brogi E; Weigelt B; Reis-Filho JS J Clin Pathol; 2022 Jan; 75(1):10-17. PubMed ID: 33148628 [TBL] [Abstract][Full Text] [Related]
19. Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium. Mafficini A; Scarpa A J Endocrinol; 2018 Mar; 236(3):R161-R167. PubMed ID: 29321190 [TBL] [Abstract][Full Text] [Related]